mebeverine has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghatak, SB; Jha, AB; Onattu, R; Panchal, SS | 1 |
| Fukushima, S; Hirose, M; Ito, N; Ozaki, K; Shirai, T; Takaba, K | 1 |
2 other study(ies) available for mebeverine and Experimental Hepatoma
| Article | Year |
|---|---|
Reduction of liver tumerogenic effect of N-nitrosodiethylamine by treatment with ɣ-oryzanol in Balb/C mice.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Diethylnitrosamine; Dose-Response Relationship, Drug; Humans; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Phenylpropionates; Xenograft Model Antitumor Assays | 2017 |
Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model.
Topics: Adenoma; Aminobiphenyl Compounds; Animals; Body Weight; Carcinogenicity Tests; Carcinoma, Hepatocellular; Hydrolyzable Tannins; Hyperplasia; Hypolipidemic Agents; Kidney; Liver; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Neoplasms, Experimental; Organ Size; Pancreatic Neoplasms; Papilloma; Paraffin; Phenylpropionates; Phytic Acid; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1991 |